Gini Deshpande is Partner of Cathay Health.
She has over 20 years of experience creating new products and launching companies across a number of sectors in life sciences. As founder and CEO of NuMedii, she pioneered the field of AI driven drug discovery, structured critical partnerships with Pharmaceutical partners and raised the Company’s initial rounds of financing.
Previously, as a consultant, she helped early stage platform companies Iperian and CollabRx identify optimal markets, enabling them to raise over $25M in financing. At life sciences tools market leader Affymetrix, she was responsible for new product opportunities for their Academic Business Unit, their largest customer segment. As director of the early stage incubation business unit at Children’s Hospital Boston (CHB), she secured grant funding to enable prototype development for six medical device products. While at CHB, she helped launch several startups in the therapeutics and diagnostics space through collaborations with faculty. She has also managed broad, diverse IP portfolios and closed licensing deals worth several million. Gini has co-authored numerous papers and is the recipient of several awards. She has served on the Advisory Committee of the BIO Investor Forum for several years and is a frequent speaker at industry conferences on AI in Healthcare.
She is an active advocate for increasing the participation of women in STEM and entrepreneurship and has also given talks at the United Nations on this topic. She is also an angel investor in companies at the intersection of technology and healthcare.
She received her PhD in Biological Sciences from Purdue University and did post-doctoral work at Harvard Medical School.
OFFICES & CONTACTS
For all general inquiries, please contact us at [email protected] or call the Paris office at +33 1 42 25 28 00
For all inquiries in regard of communication, media relations, events collaborations, please contact us at [email protected]
Tel Aviv Office Cathay Innovation Hanechoshet St.6 Tel Aviv Yafo 69710 Email : [email protected]
A global investment firm helping companies at all stages navigate the opportunities of globalization and sustainable transformation. Its platform connects people – from investors and entrepreneurs to management teams and leading corporations – across continents to share knowledge and the tools to scale, lead markets, make a positive impact and achieve the extraordinary.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.